M Wright1, J Main, H C Thomas. Show Affiliations » 1. Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, London, W2 1NY, U.K.
Abstract
Entities: Disease
Mesh： See more » Amantadine/therapeutic useAntiviral Agents/therapeutic useDrug Resistance, MicrobialHepacivirus/drug effectsHepacivirus/geneticsHepatitis B/drug therapyHepatitis B Surface Antigens/drug effectsHepatitis B e Antigens/drug effectsHepatitis B virus/drug effectsHepatitis B virus/geneticsHepatitis C/drug therapyHumansInterferon-alpha/therapeutic useLamivudine/therapeutic useMutationReverse Transcriptase Inhibitors/therapeutic useRibavirin/therapeutic use
Substances： See more » Antiviral AgentsHepatitis B Surface AntigensHepatitis B e AntigensInterferon-alphaReverse Transcriptase InhibitorsLamivudineRibavirinAmantadine
Year: 2000 PMID： 10942634 DOI： 10.1053/jinf.2000.0658
Source DB: PubMed Journal: J Infect ISSN： 0163-4453 Impact factor: 6.072